MedPath

Role of tranexamic acid in reducing perioperative blood loss in abdominal oncosurgeries in group of patients aged between 25-75years.

Phase 3
Conditions
Health Condition 1: C19- Malignant neoplasm of rectosigmoidjunction
Registration Number
CTRI/2024/06/069240
Lead Sponsor
Indira Gandhi Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ASA I,II,III

Age between 25 years-75 years undergoing abdominal oncosurgeries

Exclusion Criteria

Refusal to participate in study

Contraindication to the drug

ASA IV,V,VI patients

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath